ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 107 filers reported holding ADMA BIOLOGICS INC in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,215,238 | -38.2% | 1,736,100 | -36.3% | 5.01% | -46.3% |
| Q2 2023 | $10,059,128 | -24.0% | 2,726,051 | -31.8% | 9.34% | -17.2% |
| Q1 2023 | $13,240,000 | -14.7% | 4,000,000 | 0.0% | 11.29% | -17.7% |
| Q4 2022 | $15,520,000 | +21.2% | 4,000,000 | -24.1% | 13.71% | +8.0% |
| Q3 2022 | $12,804,000 | +6.5% | 5,269,155 | -13.2% | 12.70% | +4.1% |
| Q2 2022 | $12,026,000 | +12.9% | 6,073,598 | +4.3% | 12.20% | +23.4% |
| Q1 2022 | $10,656,000 | +40.0% | 5,822,798 | +7.9% | 9.89% | +67.4% |
| Q4 2021 | $7,611,000 | – | 5,397,798 | – | 5.91% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Velan Capital Investment Management LP | 4,000,000 | $15,520,000 | 13.71% |
| Stonepine Capital Management, LLC | 6,940,000 | $26,927,200 | 11.33% |
| Caligan Partners LP | 2,676,093 | $10,383,241 | 8.64% |
| Altium Capital Management LP | 2,870,000 | $11,135,600 | 5.66% |
| AWM Investment Company, Inc. | 6,015,000 | $23,338,200 | 3.36% |
| EAM Investors, LLC | 1,749,598 | $6,788,440 | 1.40% |
| Perceptive Advisors | 11,900,255 | $46,172,989 | 1.30% |
| EAM Global Investors LLC | 836,323 | $3,244,933 | 0.84% |
| Potomac Capital Management, Inc. | 120,000 | $466 | 0.54% |
| OBERWEIS ASSET MANAGEMENT INC/ | 536,900 | $2,083,172 | 0.44% |